Macroaxis: Personalized Investing
Simple Personalized Investing

3998 3818 0147 1234 Market Neutral Recycling Healthcare Large Value 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for ^GSPC and SLXP ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 S&P 500  vs   Salix Pharmaceuticals Ltd.
Check Correlation Matrix  
Daily Returns (%)
GSPC   SLXP   
 
Assuming 30 trading days horizon, SP 500 is expected to generate 4.56 times less return on investment than Salix. But when comparing it to its historical volatility, S&P 500 is 2.42 times less risky than Salix. It trades about 0.32 of its potential returns per unit of risk. Salix Pharmaceuticals Ltd is currently generating about 0.59 of returns per unit of risk over similar time horizon. If you would invest  5,151  in Salix Pharmaceuticals Ltd on April 25, 2013 and sell it today you would earn a total of  888  from holding Salix Pharmaceuticals Ltd or generate 17.24% return on investment over 30 days.

Diversification

Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding S&P 500 and Salix Pharmaceuticals Ltd. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.38
Parameters
Time Period1 Month [change]
DirectionPositive SLXP Moved Up vs ^GSPC
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between GSPC and SLXP with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between GSPC and SLXP to your reader
 
Share Correlation between GSPC and SLXP 
Find Opportunities
 
Predicted Return Density
 
Returns   
GSPC   SLXP   

S&P 500

 
    
SP 500
Performance
17
Out Of
100
Over 30
Days
    

Match-ups for SP 500

Vanguard Total Bond Market Index Adm vs. S&P 500
MainStay Marketfield I vs. S&P 500
Vanguard GNMA Inv vs. S&P 500
Merger vs. S&P 500
Vanguard IntermTerm Treasury Inv vs. S&P 500
SPDR S P Biotech vs. S&P 500
iShares Barclays Credit Bond vs. S&P 500
Vanguard TaxManaged Balanced Adm vs. S&P 500
Vanguard IntermTerm Bond Index Adm vs. S&P 500
Vanguard LongTerm Bond Index Inv vs. S&P 500
Permanent Portfolio vs. S&P 500
  

Salix Pharmaceuticals Ltd

 
    
Salix
Performance
32
Out Of
100
Over 30
Days
68% of all equities and portfolios perform better than Salix Pharmaceuticals Ltd. Compared with the overall equity markets, risk-adjusted returns on investments in Salix Pharmaceuticals Ltd are ranked lower than 32 (%) of all global equities and portfolios over the last 30 days.
    

Match-ups for Salix

Mylan Inc vs. Salix Pharmaceuticals Ltd
Akorn Inc vs. Salix Pharmaceuticals Ltd
Momenta Pharmaceuticals Inc vs. Salix Pharmaceuticals Ltd
Ligand Pharmaceuticals Incorporated vs. Salix Pharmaceuticals Ltd
Avanir Pharmaceuticals Inc vs. Salix Pharmaceuticals Ltd
Hi Tech Pharmacal Co Inc vs. Salix Pharmaceuticals Ltd
Supernus Pharmaceuticals Inc vs. Salix Pharmaceuticals Ltd
Health Enhancement Products Inc vs. Salix Pharmaceuticals Ltd
Catalyst Pharmaceutical Partners Inc vs. Salix Pharmaceuticals Ltd


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium